Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK ANJA BORGAARD HØYBYE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   4.3% 1.8% 3.3% 2.9% 2.7% 2.6% 13.1% 13.1%   Credit score (0-100)   49 73 55 57 60 60 18 18   Credit rating   BBB A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   995 1,734 809 925 917 1,130 0.0 0.0   EBITDA   425 1,178 310 346 375 502 0.0 0.0   EBIT   145 947 77.7 113 143 270 0.0 0.0   Pre-tax profit (PTP)   43.7 866.8 25.9 69.6 104.7 243.4 0.0 0.0   Net earnings   26.4 646.9 9.7 45.8 72.7 180.3 0.0 0.0   Pre-tax profit without non-rec. items   43.7 867 25.9 69.6 105 243 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   676 649 634 619 604 590 0.0 0.0   Shareholders equity total   226 769 684 627 585 647 445 445   Interest-bearing liabilities   1,612 1,072 967 845 762 416 0.0 0.0   Balance sheet total (assets)   2,056 2,262 1,883 1,701 1,504 1,246 445 445   Net Debt   1,612 1,072 967 845 762 416 -445 -445     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   995 1,734 809 925 917 1,130 0.0 0.0   Gross profit growth   -13.9% 74.4% -53.4% 14.3% -0.9% 23.2% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,056 2,262 1,883 1,701 1,504 1,246 445 445   Balance sheet change%   -14.3% 10.1% -16.8% -9.7% -11.6% -17.1% -64.3% 0.0%   Added value   424.7 1,177.8 310.2 345.7 375.1 502.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -560 -499 -465 -465 -465 -465 -590 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.6% 54.6% 9.6% 12.2% 15.6% 23.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.5% 43.8% 3.7% 6.3% 8.9% 19.7% 0.0% 0.0%   ROI %   7.0% 48.7% 4.2% 6.8% 9.7% 22.1% 0.0% 0.0%   ROE %   10.1% 130.0% 1.3% 7.0% 12.0% 29.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   11.0% 34.0% 36.3% 36.8% 38.9% 52.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   379.5% 91.0% 311.9% 244.5% 203.2% 82.9% 0.0% 0.0%   Gearing %   712.8% 139.4% 141.4% 134.9% 130.3% 64.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.9% 5.9% 5.1% 4.8% 4.7% 4.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.3 0.4 0.4 0.2 0.0 0.0 0.0   Current Ratio   0.0 0.3 0.4 0.4 0.2 0.0 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,732.2 -1,004.7 -692.2 -607.7 -667.8 -575.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   425 1,178 310 346 375 502 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   425 1,178 310 346 375 502 0 0   EBIT / employee   145 947 78 113 143 270 0 0   Net earnings / employee   26 647 10 46 73 180 0 0